PM&R: The Journal of Injury, Function and Rehabilitation Accepted for Coverage in Thomson Reuters' Abstracting and Indexing Database
Philadelphia, PA, August 7, 2012 -- Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce that PM&R: The Journal of Injury, Function and Rehabilitation, the official scientific journal of the American Academy of Physical Medicine and Rehabilitation (AAPM&R), has been accepted for coverage by Thomson Reuters abstracting and indexing services, including the Journal Citation Reports®.
Abstracting and indexing will begin with Volume 2:1 (2010) in Science Citation Index Expanded, Current Contents®/Clinical Medicine and Journal Citation Reports/Science Edition. The Journal will receive its first Impact Factor in 2013.
The Journal continues to gain recognition for publishing high quality research under the guidance of Editor-in-Chief Stuart M. Weinstein, MD, Clinical Professor of Rehabilitation Medicine at the University of Washington, Seattle, and an internationally renowned Editorial Board.
Dr Weinstein commented, "The senior editorial team is very excited about PM&R's selection in the Thomson Reuter's citation indexing services. This is a major milestone for our journal and will open up great opportunity for attracting high quality manuscripts from around the globe. We proudly look forward to receiving our first official impact factor in 2013."
Popularly known as the "Purple Journal," PM&R is a monthly, peer reviewed scholarly journal publishing articles that advance education and impacts the specialty of physical medicine and rehabilitation. The Journal delivers clinically relevant and evidence-based research and review information, through presenting an array of topics pertinent to physiatrists and practitioners in related medical disciplines, as well as to a wider international readership.
PM&R coverage includes acute and chronic musculoskeletal disorders and pain, neurologic conditions involving the central and peripheral nervous systems, rehabilitation of impairments associated with disabilities in adults and children, and neurophysiology and electrodiagnosis. Continuing Medical Education opportunities for AMA PRA Category 1 Credit are also offered.
About The American Academy of Physical Medicine and Rehabilitation (AAPM&R)
Founded in 1938, AAPM&R is the national medical specialty society of more than 8,000 physical medicine and rehabilitation (PM&R) physicians, also called physiatrists, who treat patients with musculoskeletal and neurological problems. PM&R physicians care for patients of all ages with acute and chronic pain, peripheral and central nervous system disorders, musculoskeletal injuries including work- and sports-related injuries. They also coordinate the long term rehabilitation process for patients with cancer, amputations and cardiopulmonary diseases. Physiatrists work closely with many other medical specialists and a variety of rehabilitation professionals in areas of psychology, physical and occupational therapy, and vocational rehabilitation.
About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Media contact
Jami Walker
Elsevier
+ 1 314 447 8987
jami.walker@elsevier.com